Find your path to Mathai
293 people in our graph share verified history with Mathai — schools, employers, funds. One of them is your warm intro.
Anna ChenunlockedMathai: together at General Atlantic (2023–2024)
Mathai: together at Xaira Therapeutics
Mathai: together at Theravance Biopharma
×3Mathai: together at Johnson & Johnson
CEO, President and Chairman at Parabilis Medicines
Intro paths
→
In turn, Mathai can intro founders to Parabilis Medicines's investors below.
Parabilis Medicines's investors · 14
ARCH Venture PartnersChicago · $50K – $250M checksCatalio Capital Management, LPNew YorkFidelity InvestmentsBoston · since 2026Foresite CapitalWest HollywoodFrazier Life SciencesPalo Alto · since 2026General CatalystSan Francisco · $30M checksGV (Google Ventures)Mountain View · $250K – $50M checks · since 2018Janus Henderson InvestorsLondon · since 2026Nextech InvestZurich · $648K – $3.2M checksNEXTECH ONCOLOGY SCSPSenningerbergRA CapitalBoston · since 2026Sixty Degree CapitalNorth YorkSoleus CapitalGreenwich · since 2026venBio PartnersSan Francisco
.png)
Experience
- Parabilis MedicinesChairman, CEO and Presidentcurrent2023 — presentCambridge, Massachusetts, United States
- Xaira TherapeuticsMember Board of Directorscurrent2023 — present
- General AtlanticExecutive Advisorcurrent2023 — present
- 10x GenomicsMember Board of Directors, Executive Advisorcurrent2017 — presentSan Francisco Bay Area
- SandozMember Board of Directors2024 — 2026
- Kelonia Therapeutics (sold to Eli Lilly)Member Board of Directors2024 — 2026
- Johnson & JohnsonExecutive Vice President, Pharmaceuticals, R&D, Johnson & Johnson2017 — 2023
- MerckSenior Vice President, Oncology, Immunooncology, CardioMetabolic diseases, Immunology2016 — 2017Rahway, NJ
- Theravance BiopharmaSenior Vice President, R&D2014 — 2016South San Francisco
- InnovivaSenior Vice President, R&D2014 — 2016
- TheravanceFounder, Senior Vice President, R&D1997 — 2014South San Francisco, CA
Skills & more
Medicinal ChemistryDrug DevelopmentDrug DiscoveryChemistryBiotechnologyLifesciencesClinical TrialsR&DFDACommercializationMedicineTherapeutic Areas
+8 more
Life SciencesBiopharmaceuticalsClinical PharmacologyPharmaceutical IndustryClinical DevelopmentOncologyStrategyImmunologyLanguages English · French
From Mathai's professional profile.
Frequently asked questions
- Who is Mathai Mammen?
- CEO, President and Chairman at Parabilis Medicines
- Where does Mathai Mammen work?
- Mathai Mammen is CEO, President and Chairman at Parabilis Medicines.
- Where did Mathai Mammen go to school?
- Mathai Mammen studied at Harvard Medical School (Doctor of Medicine - MD, Medical degree); Harvard University (Doctor of Philosophy - PhD, Chemistry); Massachusetts Institute of Technology (Doctor of Medicine - HST).
Same school
Also attended Harvard Medical School283
Niko BonatsosFounder and Managing Partner of VerdictAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
+ 277 more
Also attended Harvard University2,000
Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG
+ 1,994 more
Also attended Massachusetts Institute of Technology2,000
Fred WilsonCo-founder & Partner at Union Square VenturesElad GilSolo general partner investing through Gil CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystPhilippe LaffontFounder & CIO of Coatue ManagementNat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDG
+ 1,994 more
Also attended Dalhousie University91
Graham CareyInvestment Director - Advanced Materials at Emerald Technology Ventures AgSarah ApplebaumPartner at Pangaea Ventures Us Inc.Claire FauquierVenture Partner at Brightspark VenturesLeah MorrisExecutive Director, Encode: AI for Science at Pillar VCPaige MartinManager, Portfolio Monitoring and Valuation at White Star CapitalAmy RaePartner at Vanedge Capital
+ 85 more
Shared employers
Also worked at Parabilis Medicines4
Also worked at Xaira Therapeutics6
Also worked at Sandoz19
Nikita SharmaPrincipal at Versant VenturesCarol LynchAdvisor at Delin VenturesShreeram AradhyeInvestor at Novartis Venture FundMax PalkoPrincipal at Rockaway VenturesIain RossNon-Executive Director at TernAngela ZubelChief Development Officer, Research & Development at Debiopharm Innovation Fund
+ 13 more
Also worked at Johnson & Johnson281
Teresa ChanChief Financial Officer at Felicis VenturesKarthik ArdhanareeswaranInvestor at GV (Google Ventures)KobeFinance Director at Hummingbird VenturesMickelFinance & Risk Management at Hummingbird VenturesHal PazInvestor at Khosla VenturesNiall O'DonnellManaging Director at RiverVest Venture Partners
+ 275 more